Valuation Upgrade Spurs Rating Change
The most significant factor behind the upgrade is the shift in the valuation grade from “attractive” to “very attractive.” N G Industries currently trades at a price-to-earnings (PE) ratio of 19.94, which is considerably lower than many of its healthcare peers such as KMC Speciality (PE 44.74) and Suraksha Diagnostics (PE 48.97). The company’s price-to-book value stands at a modest 1.15, signalling undervaluation relative to its net asset base. Additionally, the enterprise value to EBITDA ratio of 20.48, while elevated, remains below some sector heavyweights like Gujarat Kidney (EV/EBITDA 52.55), indicating a more reasonable pricing for investors.
Further supporting the valuation case is the company’s dividend yield of 6.09%, which is attractive in the current low-yield environment and offers income-oriented investors a cushion amid earnings volatility. The PEG ratio is reported at 0.00, reflecting either zero or negative earnings growth expectations, which tempers enthusiasm but does not detract from the valuation appeal.
Financial Trend Remains Weak
Despite the valuation improvement, N G Industries’ financial performance continues to disappoint. The company reported flat results in Q1 FY26-27, with a 9-month PAT of just ₹1.50 crores, representing a sharp decline of 66.44% year-on-year. Operating profit growth has been negative at a -3.04% CAGR over the past five years, underscoring persistent challenges in scaling profitability.
Return on capital employed (ROCE) remains low at 3.55% for the latest period, with a half-year figure of 6.26%, signalling inefficient use of capital. The average ROCE over recent years is 4.56%, which is well below industry standards and indicates weak operational leverage. Return on equity (ROE) is similarly subdued at 5.75%, reflecting limited value creation for shareholders.
Debt servicing capacity is a concern, with an average EBIT to interest coverage ratio of only 1.31, suggesting vulnerability to interest rate fluctuations and limited buffer to meet financial obligations. The debtor turnover ratio of 34.17 times is the lowest in recent periods, hinting at potential working capital inefficiencies.
Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!
- - Expert-scrutinized selection
- - Already delivering results
- - Monthly focused approach
Quality Assessment and Market Performance
The company’s mojo grade has improved from Strong Sell to Sell, reflecting a slight enhancement in quality parameters but still signalling caution. The overall mojo score of 31.0 remains low, indicating limited confidence in the company’s near-term prospects.
Market performance over various time frames paints a mixed picture. While the stock has outperformed the Sensex in the short term, with a 1-week return of 1.29% versus Sensex’s -0.65% and a 1-month return of 2.22% against Sensex’s -3.81%, the longer-term trend is negative. Year-to-date, the stock has declined by 21.54%, and over the past year, it has fallen 25.07%, significantly underperforming the broader market’s -10.50% return. Over three years, the stock is down 14.40%, contrasting with the Sensex’s 9.91% gain, though it has delivered a strong 117.70% return over five years, outperforming the Sensex’s 25.89% in that period.
Technical Indicators and Trading Range
Technically, N G Industries is trading near the lower end of its 52-week range, with a current price of ₹117.45, close to the 52-week low of ₹110.20 and well below the high of ₹162.00. The stock’s daily trading range on 21 Sep 2026 was ₹113.40 to ₹120.00, showing some intraday volatility but limited upward momentum. The day change was a modest 0.17%, indicating a lack of strong directional conviction among traders.
Given the micro-cap status and relatively thin liquidity, technical signals should be interpreted cautiously. The downgrade in mojo grade from Strong Sell to Sell suggests some stabilisation but no clear reversal in trend.
Is N G Industries Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Peer Comparison Highlights Valuation Appeal
When compared with peers in the healthcare services sector, N G Industries stands out for its valuation attractiveness. For instance, KMC Speciality trades at a PE of 44.74 and EV/EBITDA of 25.25, while Suraksha Diagnostics commands a PE of 48.97 and EV/EBITDA of 18.19. Other companies such as Gujarat Kidney and Gaudium IVF are classified as very expensive, with PE ratios exceeding 36 and EV/EBITDA multiples above 20.
In contrast, N G Industries’ PE of 19.94 and EV/EBITDA of 20.48 place it in a more affordable category, supported by a very attractive valuation grade. Its price-to-book ratio of 1.15 is also lower than many peers, suggesting the stock is trading at a discount to its net asset value. This valuation edge is a key reason for the upgrade in mojo grade despite ongoing operational challenges.
Long-Term Outlook and Risks
Despite the valuation appeal, the company’s weak long-term fundamentals remain a concern. The negative operating profit CAGR of -3.04% over five years and poor debt servicing metrics highlight structural issues. The low ROCE and ROE figures indicate limited profitability and capital efficiency, which may constrain growth prospects.
Moreover, the stock’s underperformance relative to the broader market over the past year and three years suggests investor scepticism about the company’s ability to turnaround. The flat financial results in the recent quarter reinforce this cautious stance.
Investors should weigh the attractive valuation and dividend yield against the company’s operational weaknesses and market underperformance before making investment decisions.
Shareholding and Market Capitalisation
N G Industries is classified as a micro-cap stock with majority ownership held by promoters. This concentrated shareholding structure can be a double-edged sword, offering stability but also limiting liquidity and market float. The company’s current market price of ₹117.45 is close to recent lows, reflecting subdued investor sentiment.
Summary of Rating Change
In summary, the upgrade from Strong Sell to Sell on 18 Sep 2026 is primarily driven by a significant improvement in valuation metrics, notably the shift to a very attractive valuation grade. However, the company’s quality scores remain low due to weak financial trends, poor profitability ratios, and limited debt servicing capacity. Technical indicators show limited momentum, and the stock continues to underperform the broader market over medium to long-term horizons.
Investors are advised to consider these factors carefully, recognising that while valuation offers some upside potential, fundamental challenges and market risks persist.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
